FBTvsETF 2ETF Comparison
VS
ETF 2
Choose a second ETF to run a side-by-side ETF comparison with FBT, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
FBT performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 06/11/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FBT ETF 2 | +8.63%– | +14.03%– | +10.40%– | +38.20%– | +44.56%– | +30.74%– |
| Flows | FBT ETF 2 | +$31M– | +$23M– | +$1.12B– | +$1.16B– | +$677M– | +$382M– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FBT ETF 2 | +24.91%– | +21.21%– | +20.51%– | +22.00%– |
| Max drawdown | FBT ETF 2 | -4.56%– | -14.27%– | -19.92%– | -29.91%– |
| Max drawdown duration | FBT ETF 2 | 19d– | 126d– | 237d– | 1159d– |
Trading data
FBT | ETF 2 | |
Last sale 6/15/2026 at 1:30 PM | $227.33 | – |
| Previous close 06/12/2026 | $225.61 | – |
| Consolidated volume 06/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of May 29, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
FBT | ETF 2 | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 6/15/2026 at 1:30 PM
Live
Closed
FBT | ETF 2 | |
|---|---|---|
| Last price | $227.33 | – |
| 1D performance | +0.76% | – |
| AuM | $2.63 B | – |
| E/R | 0.54% | – |
Characteristics
FBT | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | First Trust | – |
| Benchmark | NYSE Arca Biotechnology Index | – |
| N° of holdings | 27 | – |
| Asset class | Equities | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 19, 2006 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
FBT
USA
90.25%
Other
9.75%
ETF 2
Sectors
FBT
Health Care
87.26%
Other
12.74%
ETF 2
Advertisement
Diversification
FBT
Total weight of top 15 holdings out of 15
52.3%
ETF 2
–
Top 15 holdings
Data as of April 30, 2026
FBT
NEOGENOMICS
3.86%
ADMA BIOLOGICS INC
3.69%
CORCEPT THERAPEUTICS
3.66%
ARROWHEAD PHARMACEUTICALS INC
3.54%
VERACYTE INC/D
3.54%
BIONTECH SE ADR
3.51%
BIOGEN INC
3.49%
ILLUMINA
3.45%
KRYSTAL BIOTECH INC
3.42%
AXSOME THERA CMN STK
3.42%
NATERA
3.41%
ALKERMES
3.36%
INCYTE
3.35%
EXELIXIS
3.34%
UTD THERAPEUT
3.27%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Latest news about FBT
Advertisement
